Detalhe da pesquisa
1.
Effect of ofatumumab versus placebo in relapsing multiple sclerosis patients from Japan and Russia: Phase 2 APOLITOS study.
Mult Scler
; 28(8): 1229-1238, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34787005
2.
Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study.
BMC Neurol
; 17(1): 17, 2017 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28129749
3.
Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension.
BMC Neurol
; 14: 21, 2014 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24475777